Subscribe for the Newsletter

Mobile Navigation

Exploring the Tumor Microenvironment in Cancer Treatment

May 19, 2021PTV-05-21-CL-003

Ronald Herbst, CSO of Pyxis Oncology discusses the potential of immunotherapy, understanding T cells in the tumor microenvironment, and ADCs in the company's pipeline.

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.